Somerset House Consultants has long experience of design and management of pharmaceutical development, manufacturing, and quality assurance programmes. Founded in the UK in 2001, we have an international client base covering Europe, US, Japan, Australia and India. Our expertise covers Active Pharmaceutical Ingredients, Investigational Medicinal Products, sterile and non-sterile dosage forms and biotechnology products.
Our services include:
•Setting up GMP-compliant Quality Assurance systems
•Responding to FDA and EMEA deficiency letters
•Supplier audits
•qualified person Release of Active Pharmaceutical Ingredients (API), Investigational Medicinal Products (IMP) and commercial products
•Manufacture and Release of Clinical Trial Supplies
•Contractor selection and management
•Drafting GMP-compliant Quality Agreements with suppliers and contractors
•GMP compliance
•Interim management
•Staff training
Duration : 0:3:44
Read the rest of this entry »
Technorati Tags: API, clinical trials, CONTRACT MANUFACTURER, EMEA, FDA, GMP, GMP compliance, GMP deficiency letter, Good Manufacturing Practice, IMP, MHRA, outsourcing, Pharmaceutical, quality assurance, Somerset House Consultants